Zekonyte Jurgita, Sakai Kenji, Nicoll James A R, Weller Roy O, Carare Roxana O
Faculty of Engineering and Environment, University of Southampton, UK.
Department of Neurology, Kanazawa University Hospital, Kanazawa, Japan.
Biochim Biophys Acta. 2016 May;1862(5):1047-53. doi: 10.1016/j.bbadis.2015.08.025. Epub 2015 Aug 29.
Accumulation of amyloid-β (Aβ) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of Aβ from the brain with age and Alzheimer's disease. A major pathway for elimination of Aβ and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of Aβ along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, Aβ rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E ε4 (ApoE4) mice. For drainage of Aβ to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of Aβ back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with Aβ in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/Aβ complexes to basement membrane laminin is significantly weaker than ApoE3/Aβ complexes. These results suggest that perivascular elimination of ApoE4/Aβ complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/Aβ/laminin interactions may increase the efficiency of elimination of Aβ in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
大脑斑块和动脉壁中淀粉样β蛋白(Aβ)的积累,即脑淀粉样血管病,表明随着年龄增长和患阿尔茨海默病,大脑清除Aβ的能力出现了衰退。大脑清除Aβ和其他可溶性代谢产物的主要途径是沿着脑动脉壁内的基底膜,这些基底膜代表了大脑的淋巴引流途径。Aβ沿这条血管周围途径清除的动力似乎是跟随动脉脉搏波的反向(反射)波。注入脑实质后,Aβ会迅速沿着脑动脉壁内的基底膜排出大脑;在载脂蛋白E ε4(ApoE4)小鼠中,这种排出过程会受到损害。为了使Aβ能逆着脉搏波方向排出,需要某种形式附着于基底膜,以防止后续脉搏波通过时Aβ回流到大脑中。在本研究中,我们首先表明载脂蛋白E与动脉壁基底膜引流途径中的Aβ共定位。其次,我们通过原子力显微镜观察发现,ApoE4/Aβ复合物与基底膜层粘连蛋白的附着明显弱于ApoE3/Aβ复合物。这些结果表明,血管周围清除ApoE4/Aβ复合物的效率低于其他载脂蛋白E异构体,从而增加了患阿尔茨海默病的风险。对ApoE4/Aβ/层粘连蛋白相互作用进行治疗性纠正,可能会提高预防阿尔茨海默病时Aβ的清除效率。本文是名为:《血管对认知障碍和痴呆的影响》特刊的一部分,由M. Paul Murphy、Roderick A. Corriveau和Donna M. Wilcock编辑。